Heart failure and transplantation with Dr Ileana Piņa
View all posts »HF update from ACC: Tackling readmission rates, galectin-3; chronic lung disease comorbidity
Mar 26, 2012 09:50 EDT-
1Comments
-
Read later
From the convention floor at ACC 2012, Dr Ileana Piña shares her picks of the most important developments in heart failure.
See also:
- Assay for galectin-3 approved
- Hospital admissions predict readmission for heart failure
- Lower CHF 30-day readmits: When do "we" start?
Your comments
|
||||
|
|
|
|||
|
|
|
|||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!












